What is it about?
Clostridioides difficile is a leading cause of diarrhoea in hospitals, often triggered by antibiotics, and its tendency to come back after treatment (recurrence) increases suffering, costs and risk of death. Reliable figures on recurrences were limited. We prospectively followed 309 adults with a first C. difficile infection in 15 Italian hospitals until 30 days after the end of treatment. One third of first episodes were severe or complicated, and about 11% of patients died during the study. Among those who completed follow-up, 21% had a recurrence, corresponding to 72 recurrences per 10,000 patient-days. Previous exposure to cephalosporin antibiotics was the only independent risk factor, increasing the risk of recurrence by about 70%.
Featured Image
Photo by Marcelo Leal on Unsplash
Why is it important?
This multicentre prospective study provides a robust estimate of how often C. difficile infection recurs in Italian hospitals and confirms its heavy burden. Identifying cephalosporin exposure as a risk factor supports antimicrobial stewardship to limit these antibiotics and helps target preventive strategies, such as bezlotoxumab or fidaxomicin, to patients at highest risk.
Perspectives
Clostridioides difficile has been one of the main threads of my research, and recurrences are its most frustrating aspect for patients and doctors. I am glad to have contributed to this national prospective study led by Nicola Petrosillo and Guido Granata, which gives us solid Italian data to plan prevention.
Professor Stefano Di Bella
Universita degli Studi di Trieste
Read the Original
This page is a summary of: Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections, Journal of Clinical Medicine, March 2021, MDPI AG,
DOI: 10.3390/jcm10051127.
You can read the full text:
Contributors
The following have contributed to this page







